Long-Term Efficacy and Safety of Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials
- Resource Type
- Article
- Authors
- Gettinger, Scott N.; Huber, Rudolf M.; Kim, Dong-Wan; Bazhenova, Lyudmila; Hansen, Karin Holmskov; Tiseo, Marcello; Langer, Corey J.; Paz-Ares Rodríguez, Luis G.; West, Howard L.; Reckamp, Karen L.; Weiss, Glen J.; Smit, Egbert F.; Hochmair, Maximilian J.; Kim, Sang-We; Ahn, Myung-Ju; Kim, Edward S.; Groen, Harry J.M.; Pye, Joanna; Liu, Yuyin; Zhang, Pingkuan; Vranceanu, Florin; Camidge, D. Ross
- Source
- In JTO Clinical and Research Reports September 2022 3(9)
- Subject
- Language
- ISSN
- 2666-3643